4833: Nifty at risk of further selloff below 25,050, Glenmark’s cancer drug deal and Polycab block deal | Market Minutes episode artwork

EPISODE · Sep 25, 2025 · 7 MIN

4833: Nifty at risk of further selloff below 25,050, Glenmark’s cancer drug deal and Polycab block deal | Market Minutes

from Moneycontrol Podcast · host moneycontrol

Indian markets are poised for a cautious start with the GIFT Nifty signaling a flat to mildly negative open. The Nifty failed to defend 25,100 on Wednesday amid broad-based weakness. Global cues remain mixed as Wall Street tech stocks face another round of selling and US Treasury yields edge higher, while investors await key economic data. Back home, Glenmark, Lupin and Polycab are among the stocks to watch out for today. We also track movements in oil, gold, plus other macro trends shaping sentiment. Tune in for all this and more in today’s Market Minutes — your morning podcast bringing you the top stories to kickstart your trading day, from stocks in the news to macro trends and global market cues.

Episode metadata supplied by the publisher feed · Published Sep 25, 2025

Embed this episode

Ready to play

4833: Nifty at risk of further selloff below 25,050, Glenmark’s cancer drug deal and Polycab block deal | Market Minutes

0:00 7:19

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Moneycontrol Podcast?

This episode is 7 minutes long.

When was this Moneycontrol Podcast episode published?

This episode was published on September 25, 2025.

Can I download this Moneycontrol Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!